Latest Insights - page 50 | BiopharmaTrend

AlphaFold3 Goes Open Source

DeepMind released AlphaFold3’s code, available on GitHub, marking a new stage in AI-based protein structure prediction. AlphaFold3 expands the tool's predictive abilities, now modeling proteins in complex with other biomolecules, …

Continue ›››

Tempus AI to Acquire Ambry Genetics for $600 Million

Tempus AI has announced its acquisition of Ambry Genetics, from KONICA MINOLTA, INC. for $600 million, comprising $375 million in cash and $225 million in shares. This strategic acquisition expands …

Continue ›››

BPGbio Presents AI-Guided Immune-Modulating Therapeutics at SITC 2024

BPGbio presented findings at SITC 2024 on two oncology drug candidates, BPM31510 and BRG399, aimed at advancing immune-based cancer treatments.

Continue ›››

Tango Therapeutics Shifts Focus from TNG908 to More Promising Cancer Drug Candidates, TNG462 and TNG456

Tango Therapeutics (NASDAQ: TNGX) announced that it is stopping enrollment in its TNG908 clinical trial following disappointing results for glioblastoma, a highly aggressive brain cancer. Instead, Tango will concentrate on …

Continue ›››

Research Grid Raised $6.48M to Drive Automation in Clinical Trials

Research Grid has secured $6.48 million in seed funding, led by Fuel Ventures, with additional support from Arve Capital, Ada Ventures, and Morgan Stanley Inclusive Ventures Lab, among others. The …

Continue ›››

UK Life Sciences Venture Capital Outperforms General Market: British Business Bank Report

New research from the British Business Bank reveals that life sciences venture capital (VC) funds are delivering higher realized returns for investors compared to the overall market. According to the …

Continue ›››

New AI-Enhanced Architecture for EHDS2 Implementation Released

BC Platforms, Modirum Platforms, VEIL.AI, and Productivity Leap have jointly developed a reference architecture to implement the European Health Data Space secondary (EHDS2) framework, enabling secure, AI-enhanced real-world data (RWD) …

Continue ›››

BC Platforms Unveils Platform to Unify EU Healthcare Data Governance

BC Platforms has launched its EHDS-Ready Trusted Research Environment (TRE), a platform designed to help EU healthcare institutions comply with European Health Data Space (EHDS) regulations beginning in 2025. EHDS …

Continue ›››

UK Government and Oxford Nanopore to Launch Pandemic Early Warning System

The UK government has announced partnership with life sciences company Oxford Nanopore to develop a real-time surveillance system aimed at monitoring and preventing future pandemics.

Continue ›››

AI Is Key to Democratizing Drug Discovery

Elsevier Supports Pistoia Alliance to Tackle AI Challenges in Drug Discovery

Elsevier has announced its support for the Pistoia Alliance, a non-profit organization dedicated to dismantling systemic barriers to innovation in life sciences, through a joint program of events. Founded by …

Continue ›››

Accenture Invests in 1910 Genetics to Enhance Drug Discovery With AI

Accenture Ventures has invested in 1910 Genetics, a biotechnology firm specializing in AI-driven drug discovery for both small and large molecules. This collaboration is set to integrate Accenture's AI capabilities …

Continue ›››